Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Prometic Life Sciences
Prometic Life Sciences
Activities:
Manufacturing
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Design & Build
Keyplants awarded US$1m contract by Russian biotech giant Generium
KeyPlants has been awarded a conceptual design contract for the MasterPlasma fractionation facility in the Vladimir Region of Russia
Manufacturing
ProMetic signs 15-year manufacturing contract with Emergent BioSolutions
Emergent facility in Winnipeg will manufacture plasma-derived biopharmaceuticals using the ProMetic Plasma Protein Purification System (PPPS)
Research & Development
ProMetic appoints new Chief Medical Officer
Dr John Moran will take up the role on 1 March
Research & Development
ProMetic enters CAD$1.6m development deal with leading vaccines company
For the supply of an affinity resin for use in scale-up and commercial production
Manufacturing
ProMetic and Sartorius Stedim Biotech expand collaboration
To promote turnkey solution for plasma-derived therapeutics
Research & Development
ProMetic Life Sciences and NantPharma to develop plasma-derived biopharmaceuticals
NantPharma pays initial US$2.5m to ProMetic
Manufacturing
ProMetic signs agreement to improve biopharmaceutical manufacturing process
Will receive initial service revenues of CAD800,000 during 2011
Subscribe now